Cv Sciences outlines CMS program allowing up to $500 annually in hemp-derived products as it targets positive cash flow in H2 2026

Q1 2026 earnings call recap: margins up, cost cuts, new PlusHLTH launches, CMS BEI update & cash flow outlook—read now.